Walvax Biotechnology Co., Ltd. (SHE:300142)
China flag China · Delayed Price · Currency is CNY
12.88
+0.23 (1.82%)
Apr 8, 2026, 3:04 PM CST

Walvax Biotechnology Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
20,23217,44919,32037,60164,27489,423
Market Cap Growth
4.29%-9.69%-48.62%-41.50%-28.12%50.25%
Enterprise Value
19,87117,30018,56336,11762,95988,584
Last Close Price
12.6510.8812.0423.4140.0055.91
PE Ratio
113.8698.17135.9089.6688.21209.06
Forward PE
74.4150.1637.7542.7554.6856.13
PS Ratio
8.377.226.859.1412.6425.82
PB Ratio
2.121.831.683.305.858.94
P/TBV Ratio
2.612.252.314.578.1511.16
P/FCF Ratio
--39.71199.74582.65-
P/OCF Ratio
41.2135.5418.6433.1653.50126.79
EV/Sales Ratio
8.227.156.588.7812.3825.58
EV/EBITDA Ratio
40.0335.6347.8932.2244.2795.49
EV/EBIT Ratio
190.47165.82773.0443.4653.63111.82
EV/FCF Ratio
-1067.27-38.16191.86570.72-
Debt / Equity Ratio
0.040.040.040.070.040.03
Debt / EBITDA Ratio
0.780.781.190.700.320.34
Debt / FCF Ratio
--1.014.284.19-
Net Debt / Equity Ratio
-0.13-0.13-0.28-0.31-0.31-0.31
Net Debt / EBITDA Ratio
-2.63-2.63-8.44-3.17-2.40-3.37
Net Debt / FCF Ratio
68.5368.53-6.72-18.90-30.927.85
Asset Turnover
0.180.180.190.270.350.30
Inventory Turnover
0.950.950.830.740.720.60
Quick Ratio
2.012.012.632.372.242.07
Current Ratio
2.352.352.982.732.552.37
Return on Equity (ROE)
1.19%1.19%1.52%4.57%8.94%6.74%
Return on Assets (ROA)
0.49%0.49%0.10%3.36%5.06%4.25%
Return on Invested Capital (ROIC)
0.88%0.95%0.28%9.20%14.24%10.50%
Return on Capital Employed (ROCE)
1.00%1.00%0.20%6.70%9.90%7.60%
Earnings Yield
0.88%1.02%0.74%1.11%1.13%0.48%
FCF Yield
-0.09%-0.11%2.52%0.50%0.17%-0.45%
Dividend Yield
1.23%1.42%0.08%0.04%0.03%0.05%
Payout Ratio
444.39%444.39%28.80%4.76%6.88%19.48%
Buyback Yield / Dilution
-0.05%-0.05%0.06%0.21%-1.93%-0.90%
Total Shareholder Return
1.21%1.38%0.15%0.26%-1.91%-0.85%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.